OncoQuest
Manufacturing · Canada · 11-50 Employees
View Company Info for Free
Overview
Headquarters
8123 Roper Rd NW, Edmonton, Alberta, T6E...Phone Number
(780) 448-1400Website
www.oncoquestinc.comRevenue
$8.6 MillionIndustry
ZI Rank: 1
Signal Type
Dec
Jan
Feb
Mar
Apr
May
ZI Rank
1
1
1
1
1
1
About OncoQuest
OncoQuest is a subsidiary of Quest PharmaTech Inc. (TSXV: QPT) ("Quest") and is a private biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer. OncoQuest's technology platform includes a portfolio of tumor antigen specific monoclonal immunoglobulins including CA-125, MUC1, PSA and Her2/neu. The company is exploring the therapeutic potential of these antibodies in combination with other immune modulating drugs or drug combinations to enhance tumor specific immunity and clinical outcomes.Explore more
Sell smarter with deeper company insights.
ZoomInfo gives you access to real-time firmographics, buying signals, org charts, and decision-makers - helping your GTM teams prioritize accounts, personalize outreach with AI-driven automation, and close deals faster.
Is OncoQuest your ideal customer? 
Let us give you the heads up on whether it's a good time to reach out
Competitive Alert! Recent activity has been detected by your competitor Masked Content
Check out if OncoQuest is spiking on competitors!
Earning: See what the market has to say on OncoQuest recently announced quarterly report
Product Launch: Get notified when OncoQuest launches new products
Funding: Get notified immidiatlly once OncoQuest has new funding data
Check if OncoQuest has recently received funding, and reach out quickly before it becomes old news!
Website visits: Recent activity has been detected on your website
Congratulate Masked Content for being promoted to Masked Content at OncoQuest
Click to see if OncoQuest had a recent Job posting/layoffs
OncoQuest, which may be a good buyer, showed buying intent in Masked Content Topic
Recommended Actions
Find VP level buyers at OncoQuest
Find 3 more new buyers
Compare Similar Companies to OncoQuest
Compare insights from companies similar to OncoQuest, focusing on performance, financial data, growth rates, and unique benchmarks to identify key industry trends and opportunities.
Revenue
Number of Employees
Type
Funding
Founded In
OncoQuest
$8.6M
11-50
Private
$50M
2015
N/A
Company Profile Activity
Activity Insights
OncoQuest is experiencing very low activity levels compared to other companies in the Manufacturing sector.
What does this means?
OncoQuest is drawing exceptional interest within the Manufacturing industry, suggesting notable developments or strong market momentum, learn more about OncoQuest.
OncoQuest financials insights
Gather financial insights about OncoQuest, including details on funding rounds, investors, total funding, and acquisitions, to gain a comprehensive understanding of their financial strategy.
2020
Share Placement
$50M
OncoQuest Tech Stack
A closer look at the technologies used by OncoQuest
OncoQuest News & Media
OncoQuest Announces a U.S.$50 Million Investment by KOSDAQ listed Dual Industrial Co. Ltd.
Consideration is U.S.$10 million in Cash and U.S.$40 million in a Convertible Bond EDMONTON, March 13, 2020 /PRNewswire/ - OncoQuest Inc., ("OncoQuest") a privately held, cancer immunotherapy company, a subsidiary of Quest PharmaTech Inc. (TSXV: QPT) today announced that it has closed a...OncoQuest Receives "Notice of Allowance" for Patent Protection of the Administration Schedule of Oregovomab and Chemotherapy for Stage III-IV Ovarian Cancer Patients
EDMONTON, Sept. 25, 2019 /PRNewswire/ - OncoQuest Inc., a privately held, cancer immunotherapy company today announced that a Notice of Allowance was received from the U.S. Patent and Trademark Office (USPTO) for patent protection of the schedule of administration of our monoclonal...OncoQuest Lays the Groundwork for Commencement of Phase 3 Study in Frontline Ovarian Cancer
The GOG Foundation, Inc (GOG) Letter of Authorization Executed Retention of IQVIA as global contract research organization for Phase 3 trial EDMONTON, Jan. 25, 2019 /PRNewswire/ - OncoQuest Inc., a privately held, cancer immunotherapy company, has retained the services of IQVIA, a company ...Abstract Describing Use of Oregovomab in Pancreatic Cancer to be Published in JCO as Part of ASCO 2018 Meeting
Induction of CA-125 Specific Immune Response by Oregovomab Chemoimmunotherapy in Pancreatic Cancer Patients EDMONTON, June 1, 2018 /PRNewswire/ - OncoQuest Inc. ("OncoQuest"), a privately held, cancer immunotherapy company, today announced the publication of an abstract, titled "A...
Read more news
Top Manufacturing Companies
Top companies in Australia by revenue
Top companies in United Kingdom by revenue
Frequently Asked Questions Regarding OncoQuest
Sign Up For FreeTo access detailed company insights
OncoQuest is a subsidiary of Quest PharmaTech Inc. (TSXV: QPT) ("Quest") and is a private biopharmaceutical company focused on the development and commercialization of immunotherapies for cancer. OncoQuest's technology platform includes a portfolio of tumor antigen specific monoclonal immunoglobulins including CA-125, MUC1, PSA and Her2/neu. The co... Read More
